These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

71 related items for PubMed ID: 12683748

  • 21. Stereoselective metabolism of cibenzoline, an antiarrhythmic drug, by human and rat liver microsomes: possible involvement of CYP2D and CYP3A.
    Niwa T, Shiraga T, Mitani Y, Terakawa M, Tokuma Y, Kagayama A.
    Drug Metab Dispos; 2000 Sep; 28(9):1128-34. PubMed ID: 10950860
    [Abstract] [Full Text] [Related]

  • 22. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
    Draper AJ, Madan A, Parkinson A.
    Arch Biochem Biophys; 1997 May 01; 341(1):47-61. PubMed ID: 9143352
    [Abstract] [Full Text] [Related]

  • 23. Effects of cytochrome P-450 inhibitors on the in vivo metabolism of all-trans-retinoic acid in rats.
    Van Wauwe JP, Coene MC, Goossens J, Cools W, Monbaliu J.
    J Pharmacol Exp Ther; 1990 Jan 01; 252(1):365-9. PubMed ID: 2299598
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents.
    Stoppie P, Borgers M, Borghgraef P, Dillen L, Goossens J, Sanz G, Szel H, Van Hove C, Van Nyen G, Nobels G, Vanden Bossche H, Venet M, Willemsens G, Van Wauwe J.
    J Pharmacol Exp Ther; 2000 Apr 01; 293(1):304-12. PubMed ID: 10734183
    [Abstract] [Full Text] [Related]

  • 30. The xenobiotic inhibitor profile of cytochrome P4502C8.
    Ong CE, Coulter S, Birkett DJ, Bhasker CR, Miners JO.
    Br J Clin Pharmacol; 2000 Dec 01; 50(6):573-80. PubMed ID: 11136296
    [Abstract] [Full Text] [Related]

  • 31. Molecular recognition of CYP26A1 binding pockets and structure-activity relationship studies for design of potent and selective retinoic acid metabolism blocking agents.
    Sun B, Song S, Hao CZ, Huang WX, Liu CC, Xie HL, Lin B, Cheng MS, Zhao DM.
    J Mol Graph Model; 2015 Mar 01; 56():10-9. PubMed ID: 25541526
    [Abstract] [Full Text] [Related]

  • 32. Identification and characterization of potent CYP3A4 inhibitors in Schisandra fruit extract.
    Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T.
    Drug Metab Dispos; 2004 Dec 01; 32(12):1351-8. PubMed ID: 15342469
    [Abstract] [Full Text] [Related]

  • 33. Significance of metabolism in the disposition and action of the antidysrhythmic drug, dofetilide. In vitro studies and correlation with in vivo data.
    Walker DK, Alabaster CT, Congrave GS, Hargreaves MB, Hyland R, Jones BC, Reed LJ, Smith DA.
    Drug Metab Dispos; 1996 Apr 01; 24(4):447-55. PubMed ID: 8801060
    [Abstract] [Full Text] [Related]

  • 34. Some coumarins and triphenylethene derivatives as inhibitors of human testes microsomal 17beta-hydroxysteroid dehydrogenase (17beta-HSD type 3): further studies with tamoxifen on the rat testes microsomal enzyme.
    LE Lain R, Barrell KJ, Saeed GS, Nicholls PJ, Simons C, Kirby A, Smith HJ.
    J Enzyme Inhib Med Chem; 2002 Apr 01; 17(2):93-100. PubMed ID: 12420755
    [Abstract] [Full Text] [Related]

  • 35. Cyclic conversion of the novel Src kinase inhibitor [7-(2,6-dichloro-phenyl)-5-methyl-benzo[1,2,4]triazin-3-yl]-[4-(2-pyrrolidin-1-yl-ethoxy)-phenyl]-amine (TG100435) and Its N-oxide metabolite by flavin-containing monoxygenases and cytochrome P450 reductase.
    Kousba A, Soll R, Yee S, Martin M.
    Drug Metab Dispos; 2007 Dec 01; 35(12):2242-51. PubMed ID: 17881660
    [Abstract] [Full Text] [Related]

  • 36. Analysis of the oxidative catabolism of retinoic acid in rat Dunning R3327G prostate tumors.
    Krekels MD, Zimmerman J, Janssens B, Van Ginckel R, Cools W, Van Hove C, Coene MC, Wouters W.
    Prostate; 1996 Jul 01; 29(1):36-41. PubMed ID: 8685053
    [Abstract] [Full Text] [Related]

  • 37. Hepatic microsomal cytochrome P450 enzyme activity in relation to in vitro metabolism/inhibition of polychlorinated biphenyls and testosterone in Baltic grey seal (Halichoerus grypus).
    Li H, Boon JP, Lewis WE, van den Berg M, Nyman M, Letcher RJ.
    Environ Toxicol Chem; 2003 Mar 01; 22(3):636-44. PubMed ID: 12627653
    [Abstract] [Full Text] [Related]

  • 38. Biochemical and pharmacological profile of a tetrasubstituted furanone as a highly selective COX-2 inhibitor.
    Riendeau D, Percival MD, Boyce S, Brideau C, Charleson S, Cromlish W, Ethier D, Evans J, Falgueyret JP, Ford-Hutchinson AW, Gordon R, Greig G, Gresser M, Guay J, Kargman S, Léger S, Mancini JA, O'Neill G, Ouellet M, Rodger IW, Thérien M, Wang Z, Webb JK, Wong E, Chan CC.
    Br J Pharmacol; 1997 May 01; 121(1):105-17. PubMed ID: 9146894
    [Abstract] [Full Text] [Related]

  • 39. The CYP26 inhibitor R115866 potentiates the effects of all-trans retinoic acid on cultured human epidermal keratinocytes.
    Giltaire S, Herphelin F, Frankart A, Hérin M, Stoppie P, Poumay Y.
    Br J Dermatol; 2009 Mar 01; 160(3):505-13. PubMed ID: 19120344
    [Abstract] [Full Text] [Related]

  • 40. The involvement of cytochrome p450 (CYP) 26 in the retinoic acid metabolism of human epidermal keratinocytes.
    Pavez Loriè E, Li H, Vahlquist A, Törmä H.
    Biochim Biophys Acta; 2009 Mar 01; 1791(3):220-8. PubMed ID: 19171200
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 4.